Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DAISY C CORTES

Allopathic & Osteopathic Physicians Pediatrics Pediatric Hematology-Oncology

NPI
1215234356
CMS profile
326683
Location
LAS VEGAS, NV

General Payments · PY2018–2024

$235,256.69

  • Reported across 398 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$69,947.37

65 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $45,175.19 26
Bayer HealthCare Pharmaceuticals Inc. $13,525.22 14
GENZYME CORPORATION $6,722.72 6
Octapharma USA, Inc. $4,180.41 10
Genentech, Inc. $189.58 4
Kedrion Biopharma, Inc. $76.17 2
PFIZER INC. $50.48 2
MEDAC PHARMA, INC. $27.60 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $979.70 30
PY2019 $16,110.65 105
PY2020 $5,090.19 38
PY2021 $45,788.28 61
PY2022 $76,797.67 81
PY2023 $20,542.83 18
PY2024 $69,947.37 65

Payment records · PY2024 (65)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Bayer Healthcare Pharmaceuticals Inc. $195.62 05/31/2024 Travel and Lodging Undisputed 01/23/2026 1086078320 CMS
Bayer Healthcare Pharmaceuticals Inc. $285.10 05/31/2024 Travel and Lodging Undisputed 01/23/2026 1086078374 CMS
Bayer Healthcare Pharmaceuticals Inc. $28.89 05/31/2024 Food and Beverage Undisputed 01/23/2026 1086267727 CMS
Bayer Healthcare Pharmaceuticals Inc. $114.75 05/31/2024 Food and Beverage Undisputed 01/23/2026 1086267729 CMS
Bayer Healthcare Pharmaceuticals Inc. $952.05 06/01/2024 Travel and Lodging Undisputed 01/23/2026 1086078280 CMS
Bayer Healthcare Pharmaceuticals Inc. $195.62 06/01/2024 Travel and Lodging Undisputed 01/23/2026 1086078282 CMS
Bayer Healthcare Pharmaceuticals Inc. $31.62 06/01/2024 Food and Beverage Undisputed 01/23/2026 1086116002 CMS
Bayer Healthcare Pharmaceuticals Inc. $11,152.00 06/01/2024 Consulting Fee Undisputed 01/23/2026 1086142515 CMS
Bayer Healthcare Pharmaceuticals Inc. $150.15 06/01/2024 Food and Beverage Undisputed 01/23/2026 1086142517 CMS
Bayer Healthcare Pharmaceuticals Inc. $74.25 06/01/2024 Food and Beverage Undisputed 01/23/2026 1086142519 CMS
Bayer Healthcare Pharmaceuticals Inc. $41.21 06/01/2024 Food and Beverage Undisputed 01/23/2026 1086147699 CMS
Bayer Healthcare Pharmaceuticals Inc. $46.11 06/01/2024 Food and Beverage Undisputed 01/23/2026 1086147701 CMS
Bayer Healthcare Pharmaceuticals Inc. $60.75 06/01/2024 Food and Beverage Undisputed 01/23/2026 1086267725 CMS
Bayer Healthcare Pharmaceuticals Inc. $197.10 06/02/2024 Travel and Lodging Undisputed 01/23/2026 1086078354 CMS
Genentech, Inc. $38.86 06/24/2024 Food and Beverage Undisputed 01/23/2026 1132992842 CMS
Genentech, Inc. $49.99 10/14/2024 Food and Beverage Undisputed 01/23/2026 1132992846 CMS
Genentech, Inc. $19.49 10/14/2024 Food and Beverage Undisputed 01/23/2026 1132992850 CMS
Genentech, Inc. $81.24 12/09/2024 Food and Beverage Undisputed 01/23/2026 1132992854 CMS
GENZYME CORPORATION $166.76 09/28/2024 Food and Beverage Undisputed 01/23/2026 1139837981 CMS
GENZYME CORPORATION $352.49 09/28/2024 Travel and Lodging Undisputed 01/23/2026 1139837983 CMS
GENZYME CORPORATION $276.47 09/28/2024 Travel and Lodging Undisputed 01/23/2026 1139837985 CMS
GENZYME CORPORATION $5,763.00 09/28/2024 Consulting Fee Undisputed 01/23/2026 1139837987 CMS
GENZYME CORPORATION $40.45 10/15/2024 Food and Beverage Undisputed 01/23/2026 1139837957 CMS
GENZYME CORPORATION $123.55 11/21/2024 Food and Beverage Undisputed 01/23/2026 1139837979 CMS
Kedrion Biopharma, Inc. $52.40 01/18/2024 Food and Beverage Undisputed 01/23/2026 1125861215 CMS
Kedrion Biopharma, Inc. $23.77 11/15/2024 Food and Beverage Undisputed 01/23/2026 1125861221 CMS
Medexus Pharma, Inc. $27.60 11/16/2024 Food and Beverage Undisputed 01/23/2026 1125860401 CMS
Novo Nordisk Inc $253.00 02/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1097491126 CMS
Novo Nordisk Inc $14.17 02/28/2024 Food and Beverage Undisputed 01/23/2026 1097076401 CMS
Novo Nordisk Inc $2,380.00 02/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1097329032 CMS
Novo Nordisk Inc $121.85 02/29/2024 Food and Beverage Undisputed 01/23/2026 1096700140 CMS
Novo Nordisk Inc $7,586.25 02/29/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1097491115 CMS
Novo Nordisk Inc $183.34 02/29/2024 Travel and Lodging Undisputed 01/23/2026 1097657985 CMS
Novo Nordisk Inc $253.00 03/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1097377483 CMS
Novo Nordisk Inc $3,867.50 03/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1097489825 CMS
Novo Nordisk Inc $47.36 03/24/2024 Food and Beverage Undisputed 01/23/2026 1097699808 CMS
Novo Nordisk Inc $125.00 06/23/2024 Food and Beverage Undisputed 01/23/2026 1097259587 CMS
Novo Nordisk Inc $253.00 07/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1097693125 CMS
Novo Nordisk Inc $2,380.00 07/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1096681839 CMS
Novo Nordisk Inc $1,190.00 08/07/2024 Consulting Fee Undisputed 01/23/2026 1097693215 CMS
Novo Nordisk Inc $366.80 08/08/2024 Travel and Lodging Undisputed 01/23/2026 1096861543 CMS
Novo Nordisk Inc $349.26 08/08/2024 Food and Beverage Undisputed 01/23/2026 1097496388 CMS
Novo Nordisk Inc $11,751.25 08/08/2024 Consulting Fee Undisputed 01/23/2026 1097496965 CMS
Novo Nordisk Inc $1,078.79 08/08/2024 Travel and Lodging Undisputed 01/23/2026 1097497374 CMS
Novo Nordisk Inc $535.06 08/08/2024 Travel and Lodging Undisputed 01/23/2026 1097526837 CMS
Novo Nordisk Inc $647.09 08/17/2024 Travel and Lodging Undisputed 01/23/2026 1096933975 CMS
Novo Nordisk Inc $137.96 08/17/2024 Travel and Lodging Undisputed 01/23/2026 1097057226 CMS
Novo Nordisk Inc $137.96 08/17/2024 Travel and Lodging Undisputed 01/23/2026 1097259845 CMS
Novo Nordisk Inc $4,611.75 08/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1097328147 CMS
Novo Nordisk Inc $647.09 08/17/2024 Travel and Lodging Undisputed 01/23/2026 1097470210 CMS
Novo Nordisk Inc $6,098.75 08/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1097838206 CMS
Novo Nordisk Inc $33.96 11/07/2024 Food and Beverage Undisputed 01/23/2026 1097824841 CMS
Novo Nordisk Inc $125.00 12/07/2024 Food and Beverage Undisputed 01/23/2026 1097031100 CMS
Octapharma USA, Inc. $2,400.00 10/18/2024 Honoraria Undisputed 01/23/2026 1142313512 CMS
Octapharma USA, Inc. $846.95 10/18/2024 Travel and Lodging Undisputed 01/23/2026 1142313514 CMS
Octapharma USA, Inc. $134.00 10/18/2024 Travel and Lodging Undisputed 01/23/2026 1142313516 CMS
Octapharma USA, Inc. $89.75 10/18/2024 Travel and Lodging Undisputed 01/23/2026 1142313518 CMS
Octapharma USA, Inc. $248.74 10/18/2024 Travel and Lodging Undisputed 01/23/2026 1142313520 CMS
Octapharma USA, Inc. $7.00 10/18/2024 Food and Beverage Undisputed 01/23/2026 1142313522 CMS
Octapharma USA, Inc. $17.00 10/18/2024 Food and Beverage Undisputed 01/23/2026 1142313524 CMS
Octapharma USA, Inc. $271.34 10/18/2024 Food and Beverage Undisputed 01/23/2026 1142313526 CMS
Octapharma USA, Inc. $103.01 10/18/2024 Travel and Lodging Undisputed 01/23/2026 1142313528 CMS
Octapharma USA, Inc. $62.62 10/18/2024 Travel and Lodging Undisputed 01/23/2026 1142313530 CMS
PFIZER INC. $30.16 08/12/2024 Food and Beverage Undisputed 01/23/2026 1131600445 CMS
PFIZER INC. $20.32 11/12/2024 Food and Beverage Undisputed 01/23/2026 1131600449 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.